Topical Antibiotics and Intravitreous Injections

The recruitment status of this study is unknown because the information has not been verified recently.

Verified December 2006 by Stanford University.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Stanford University

ClinicalTrials.gov Identifier:

NCT00410891

First received: October 2, 2006

Last updated: December 11, 2006

Last verified: December 2006

History of Changes

Tracking Information

First Received Date ^ICMJE

October 2, 2006

Last Updated Date

December 11, 2006

Start Date ^ICMJE

Not Provided

Primary Completion Date

Not Provided

Current Primary Outcome Measures ^ICMJE

Not Provided

Original Primary Outcome Measures ^ICMJE

Not Provided

Change History

Complete list of historical versions of study NCT00410891 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Not Provided

Original Secondary Outcome Measures ^ICMJE

Not Provided

Current Other Outcome Measures ^ICMJE

Not Provided

Original Other Outcome Measures ^ICMJE

Not Provided

Descriptive Information

Brief Title ^ICMJE

Topical Antibiotics and Intravitreous Injections

Official Title ^ICMJE

Not Provided

Brief Summary

Evaluation of efficacy of topical preoperative antibiotics in patients undergoing intravitreous injections.

Detailed Description

Not Provided

Study Type ^ICMJE

Interventional

Study Phase

Phase 4

Study Design ^ICMJE

Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind

Condition ^ICMJE

Intravitreous
Injections

Intervention ^ICMJE

Drug: gatifloxacin

Study Arm (s)

Not Provided

Publications *

Not Provided

* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Recruiting

Enrollment ^ICMJE

Not Provided

Completion Date

Not Provided

Primary Completion Date

Not Provided

Eligibility Criteria ^ICMJE

Inclusion Criteria:

intravitreous injection

Exclusion Criteria:

antibiotic use

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Not Provided

Contacts ^ICMJE

Contact: Christopher Ta, MD

650-725-5743

Location Countries ^ICMJE

United States

Administrative Information

NCT Number ^ICMJE

NCT00410891

Other Study ID Numbers ^ICMJE

96803 (eProtocol 4384

Has Data Monitoring Committee

Not Provided

Responsible Party

Not Provided

Study Sponsor ^ICMJE

Stanford University

Collaborators ^ICMJE

Not Provided

Investigators ^ICMJE

Principal Investigator:

Christopher Ta, MD

Stanford University

Information Provided By

Stanford University

Verification Date

December 2006

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top